Ascension St. Mary's Hospital is a hospital in Saginaw, Michigan, United States. Ascension St. Mary's is certified as a Comprehensive Stroke Center by The Joint Commission.

During the past decade, Ascension Saint Mary's Hospital conducted 147 clinical trials. In the 10-year time frame, 147 clinical trials started and 146 clinical trials were completed, i.e. on average, 99.3% percent of trials that started reached the finish line to date. In the past 5 years, 41 clinical trials started and 65 clinical trials were completed. i.e. 158.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ascension Saint Mary's Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 174 trials, followed by "Alliance for Clinical Trials in Oncology" with 42 trials sponsored, "SWOG Cancer Research Network" with 41 trials sponsored, "Radiation Therapy Oncology Group" with 23 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 23 trials sponsored. Other sponsors include 49 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ascension Saint Mary's Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 160 trials as a collaborator, "NRG Oncology" with 49 trials as a collaborator, "Canadian Cancer Trials Group" with 9 trials as a collaborator, "Cancer and Leukemia Group B" with 7 trials as a collaborator and "NCIC Clinical Trials Group" with 7 trials as a collaborator. Other collaborators include 70 different institutions and companies that were collaborators in the rest 49 trials.

According to Clinical.Site data, the most researched conditions in "Ascension Saint Mary's Hospital" are "Recurrent Breast Carcinoma" (13 trials), "Stage IV Lung Cancer AJCC v8" (12 trials), "Recurrent Ovarian Carcinoma" (11 trials), "Stage IV Breast Cancer AJCC v6 and v7" (11 trials) and "Breast Cancer" (10 trials). Many other conditions were trialed in "Ascension Saint Mary's Hospital" in a lesser frequency.

Most popular intervention types in "Ascension Saint Mary's Hospital" are "Drug" (286 trials), "Other" (204 trials), "Biological" (126 trials), "Procedure" (73 trials) and "Radiation" (67 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (109 trials), "Quality-of-Life Assessment" (83 trials), "Paclitaxel" (43 trials), "Questionnaire Administration" (43 trials) and "Carboplatin" (37 trials). Other intervention names were less common.

The vast majority of trials in "Ascension Saint Mary's Hospital" are 272 trials for "All" genders, 61 trials for "Female" genders and 19 trials for "Male" genders.

Currently, there are NaN active trials in "Ascension Saint Mary's Hospital". undefined are not yet recruiting, 72 are recruiting, 133 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 112 completed trials in Ascension Saint Mary's Hospital, 8 suspended trials, and 23 terminated clinical trials to date.

Out of the total trials that were conducted in Ascension Saint Mary's Hospital, 16 "Phase 1" clinical trials were conducted, 184 "Phase 2" clinical trials and 165 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 12 trials that are defined as “Not Applicable".